MGMT and glioblastoma: In our study, we investigated OS and PFS in GBM according to MGMT promoter methylation profile and chromosome 10q status and showed that the combination chromosome 10q26 loss with hypermethylation of the MGMT promoter in patients with GBM is an interesting prognostic tool associated with longer OS (P = .002) and PFS (P = .03).